• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

在气血屏障阵列中对人类中性粒细胞募集和功能反应进行高通量定量分析。

High-throughput quantitation of human neutrophil recruitment and functional responses in an air-blood barrier array.

作者信息

Viola Hannah, Chen Liang-Hsin, Jo Seongbin, Washington Kendra, Selva Cauviya, Li Andrea, Feng Daniel, Giacalone Vincent, Stephenson Susan T, Cottrill Kirsten, Mohammad Ahmad, Williams Evelyn, Qu Xianggui, Lam Wilbur, Ng Nga L, Fitzpatrick Anne, Grunwell Jocelyn, Tirouvanziam Rabindra, Takayama Shuichi

机构信息

Wallace H. Coulter Department of Biomedical Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.

School of Chemical and Biomolecular Engineering, Georgia Institute of Technology, Atlanta, Georgia 30332, USA.

出版信息

APL Bioeng. 2025 Apr 25;9(2):026110. doi: 10.1063/5.0220367. eCollection 2025 Jun.

DOI:10.1063/5.0220367
PMID:40290728
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC12033047/
Abstract

Dysregulated neutrophil recruitment drives many pulmonary diseases, but most preclinical screening methods are unsuited to evaluate pulmonary neutrophilia, limiting progress toward therapeutics. Namely, high-throughput therapeutic assays typically exclude critical neutrophilic pathophysiology, including blood-to-lung recruitment, dysfunctional activation, and resulting impacts on the air-blood barrier. To meet the conflicting demands of physiological complexity and high throughput, we developed an assay of 96-well leukocyte recruitment in an air-blood barrier array (L-ABBA-96) that enables -like neutrophil recruitment compatible with downstream phenotyping by automated flow cytometry. We modeled acute respiratory distress syndrome (ARDS) with neutrophil recruitment to 20 ng/mL epithelial-side interleukin 8 and found a dose-dependent reduction in recruitment with physiologic doses of baricitinib, a JAK1/2 inhibitor recently Food and Drug Administration-approved for severe Coronavirus Disease 2019 ARDS. Additionally, neutrophil recruitment to patient-derived cystic fibrosis sputum supernatant induced disease-mimetic recruitment and activation of healthy donor neutrophils and upregulated endothelial e-selectin. Compared to 24-well assays, the L-ABBA-96 reduces required patient sample volumes by 25 times per well and quadruples throughput per plate. Compared to microfluidic assays, the L-ABBA-96 recruits two orders of magnitude more neutrophils per well, enabling downstream flow cytometry and other standard biochemical assays. This novel pairing of high-throughput modeling of organ-level lung function with parallel high-throughput leukocyte phenotyping substantially advances opportunities for pathophysiological studies, personalized medicine, and drug testing applications.

摘要

中性粒细胞募集失调会引发多种肺部疾病,但大多数临床前筛查方法都不适用于评估肺部中性粒细胞增多症,这限制了治疗方面的进展。具体而言,高通量治疗性检测通常排除了关键的中性粒细胞病理生理学因素,包括血液到肺部的募集、功能失调的激活以及对气血屏障的影响。为了满足生理复杂性和高通量的相互冲突的需求,我们开发了一种在气血屏障阵列中进行96孔白细胞募集的检测方法(L-ABBA-96),该方法能够实现类似中性粒细胞的募集,并通过自动流式细胞术与下游表型分析兼容。我们用中性粒细胞募集到20 ng/mL上皮侧白细胞介素8来模拟急性呼吸窘迫综合征(ARDS),并发现使用生理剂量的巴瑞替尼(一种最近被美国食品药品监督管理局批准用于严重2019冠状病毒病ARDS的JAK1/2抑制剂)会使募集呈剂量依赖性减少。此外,中性粒细胞募集到患者来源的囊性纤维化痰液上清液会诱导疾病模拟性募集并激活健康供体的中性粒细胞,并上调内皮细胞E-选择素。与24孔检测相比,L-ABBA-96每孔所需的患者样本量减少了25倍,每板通量提高了四倍。与微流控检测相比,L-ABBA-96每孔募集的中性粒细胞多两个数量级,能够进行下游流式细胞术和其他标准生化检测。这种将器官水平肺功能的高通量建模与并行高通量白细胞表型分析相结合的新方法极大地推进了病理生理学研究、个性化医疗和药物测试应用的机会。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/428d/12033047/98381729d02f/ABPID9-000009-026110_1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/428d/12033047/efdbf363d983/ABPID9-000009-026110_1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/428d/12033047/37db5bf57b29/ABPID9-000009-026110_1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/428d/12033047/e7f6e6fe4df9/ABPID9-000009-026110_1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/428d/12033047/98381729d02f/ABPID9-000009-026110_1-g004.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/428d/12033047/efdbf363d983/ABPID9-000009-026110_1-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/428d/12033047/37db5bf57b29/ABPID9-000009-026110_1-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/428d/12033047/e7f6e6fe4df9/ABPID9-000009-026110_1-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/428d/12033047/98381729d02f/ABPID9-000009-026110_1-g004.jpg

相似文献

1
High-throughput quantitation of human neutrophil recruitment and functional responses in an air-blood barrier array.在气血屏障阵列中对人类中性粒细胞募集和功能反应进行高通量定量分析。
APL Bioeng. 2025 Apr 25;9(2):026110. doi: 10.1063/5.0220367. eCollection 2025 Jun.
2
HIGH THROUGHPUT QUANTITATION OF HUMAN NEUTROPHIL RECRUITMENT AND FUNCTIONAL RESPONSES IN AN AIR-BLOOD BARRIER ARRAY.气-血屏障阵列中人类中性粒细胞募集和功能反应的高通量定量分析
bioRxiv. 2024 May 14:2024.05.10.593624. doi: 10.1101/2024.05.10.593624.
3
[Standard technical specifications for methacholine chloride (Methacholine) bronchial challenge test (2023)].[氯化乙酰甲胆碱支气管激发试验标准技术规范(2023年)]
Zhonghua Jie He He Hu Xi Za Zhi. 2024 Feb 12;47(2):101-119. doi: 10.3760/cma.j.cn112147-20231019-00247.
4
SB-656933, a novel CXCR2 selective antagonist, inhibits ex vivo neutrophil activation and ozone-induced airway inflammation in humans.SB-656933 是一种新型的 CXCR2 选择性拮抗剂,可抑制体外中性粒细胞激活和臭氧诱导的人类气道炎症。
Br J Clin Pharmacol. 2011 Aug;72(2):282-93. doi: 10.1111/j.1365-2125.2011.03968.x.
5
Manipulating the air-filled zebrafish swim bladder as a neutrophilic inflammation model for acute lung injury.将充满空气的斑马鱼鳔作为急性肺损伤的中性粒细胞炎症模型进行操作。
Cell Death Dis. 2016 Nov 10;7(11):e2470. doi: 10.1038/cddis.2016.365.
6
Increased neutrophil migratory activity after major trauma: a factor in the etiology of acute respiratory distress syndrome?严重创伤后中性粒细胞迁移活性增加:急性呼吸窘迫综合征病因中的一个因素?
Crit Care Med. 2002 Aug;30(8):1717-21. doi: 10.1097/00003246-200208000-00007.
7
Establishment of a scalable microfluidic assay for characterization of population-based neutrophil chemotaxis.建立一种用于表征群体中性粒细胞趋化性的可扩展微流控分析方法。
Allergy. 2020 Jun;75(6):1382-1393. doi: 10.1111/all.14195. Epub 2020 Feb 11.
8
A microfluidic device for assessment of E-selectin-mediated neutrophil recruitment to inflamed endothelium and prediction of therapeutic response in sickle cell disease.用于评估 E-选择素介导的中性粒细胞向炎症内皮细胞募集并预测镰状细胞病治疗反应的微流控装置。
Biosens Bioelectron. 2023 Feb 15;222:114921. doi: 10.1016/j.bios.2022.114921. Epub 2022 Nov 24.
9
A Phase I/II Clinical Trial to evaluate the efficacy of baricitinib to prevent respiratory insufficiency progression in onco-hematological patients affected with COVID19: A structured summary of a study protocol for a randomised controlled trial.一项评估巴瑞替尼预防 COVID19 相关血液肿瘤患者呼吸功能不全进展的疗效的 I/II 期临床试验:一项随机对照试验研究方案的结构化总结。
Trials. 2021 Feb 5;22(1):116. doi: 10.1186/s13063-021-05072-4.
10
Pulmonary endothelial activation caused by extracellular histones contributes to neutrophil activation in acute respiratory distress syndrome.细胞外组蛋白引起的肺内皮细胞激活促成急性呼吸窘迫综合征中的中性粒细胞激活。
Respir Res. 2016 Nov 21;17(1):155. doi: 10.1186/s12931-016-0472-y.

本文引用的文献

1
Liquid plug propagation in computer-controlled microfluidic airway-on-a-chip with semi-circular microchannels.液塞在具有半圆形微通道的计算机控制微流控气道芯片中的传播。
Lab Chip. 2024 Jan 17;24(2):197-209. doi: 10.1039/d3lc00957b.
2
A protocol for high-throughput screening for immunomodulatory compounds using human primary cells.一种使用人原代细胞进行免疫调节化合物高通量筛选的方案。
STAR Protoc. 2023 Sep 15;4(3):102405. doi: 10.1016/j.xpro.2023.102405. Epub 2023 Jul 13.
3
Advances in TEER measurements of biological barriers in microphysiological systems.
微生理系统中生物屏障的 TEER 测量的进展。
Biosens Bioelectron. 2023 Aug 15;234:115355. doi: 10.1016/j.bios.2023.115355. Epub 2023 Apr 26.
4
In Vitro (Trans)Migration Experiment Using Chemokines as Stimulatory Factor.以趋化因子作为刺激因子的体外(跨)迁移实验
Methods Mol Biol. 2023;2597:77-87. doi: 10.1007/978-1-0716-2835-5_7.
5
Specific circulating neutrophils subsets are present in clinically stable adults with cystic fibrosis and are further modulated by pulmonary exacerbations.特定的循环中性粒细胞亚群存在于临床稳定的囊性纤维化成人中,并进一步受肺部加重的调节。
Front Immunol. 2022 Sep 29;13:1012310. doi: 10.3389/fimmu.2022.1012310. eCollection 2022.
6
Nanomedicine platform for targeting activated neutrophils and neutrophil-platelet complexes using an α-antitrypsin-derived peptide motif.基于α-抗胰蛋白酶衍生肽基序的靶向活化中性粒细胞和中性粒细胞-血小板复合物的纳米医学平台。
Nat Nanotechnol. 2022 Sep;17(9):1004-1014. doi: 10.1038/s41565-022-01161-w. Epub 2022 Jul 18.
7
Glucocorticoid therapy in respiratory illness: bench to bedside.糖皮质激素在呼吸系统疾病中的治疗:从基础到临床。
J Investig Med. 2022 Dec;70(8):1662-1680. doi: 10.1136/jim-2021-002161. Epub 2022 Jun 28.
8
Baricitinib Is First Approved COVID-19 Immunomodulatory Treatment.巴瑞替尼是首个获批的用于治疗新冠肺炎的免疫调节药物。
JAMA. 2022 Jun 21;327(23):2281. doi: 10.1001/jama.2022.9846.
9
Organ-on-a-chip: current gaps and future directions.器官芯片:当前的差距和未来的方向。
Biochem Soc Trans. 2022 Apr 29;50(2):665-673. doi: 10.1042/BST20200661.
10
Physiologically-Based Pharmacokinetic Modelling to Investigate Baricitinib and Tofacitinib Dosing Recommendations for COVID-19 in Geriatrics.基于生理学的药代动力学模型研究巴瑞替尼和托法替布在老年 COVID-19 中的剂量推荐。
Clin Pharmacol Ther. 2022 Aug;112(2):291-296. doi: 10.1002/cpt.2600. Epub 2022 Apr 27.